Medications

Industry executives: Profits drive rising prices for MS drugs

U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year. And, even though drug companies have provided no new treatment breakthroughs, the price ...

Diseases, Conditions, Syndromes

Governments urged to adopt compensation for rare vaccine injury

Research led by The University of Western Australia has found that that most countries with mandatory childhood vaccination policies don't have no-fault vaccine injury compensation schemes to care for rare victims of vaccines.

Medical economics

Poverty, racism and the public health crisis in America

Although extreme poverty in the United States is low by global standards, the U.S. has the worst index of health and social problems as a function of income inequality. In a newly published article, Bettina Beech, clinical ...

page 2 from 2